Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
injection
|
| gptkbp:approvedBy |
1985
|
| gptkbp:ATCCode |
L02AE02
|
| gptkbp:brand |
Eligard
Fensolvi Viadur leuprolide acetate |
| gptkbp:CASNumber |
53714-56-0
|
| gptkbp:chemicalFormula |
C59H84N16O12
|
| gptkbp:contraindication |
pregnancy
hypersensitivity to leuprolide |
| gptkbp:FDAApproved |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lupron
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:AbbVie
|
| gptkbp:mechanismOfAction |
GnRH agonist
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:routeOfAdministration |
intramuscular
subcutaneous |
| gptkbp:sideEffect |
decreased libido
injection site reactions hot flashes bone density loss |
| gptkbp:usedFor |
prostate cancer
transgender hormone therapy endometriosis uterine fibroids precocious puberty |
| gptkbp:bfsParent |
gptkb:Takeda
gptkb:Takeda_(Japan) |
| gptkbp:bfsLayer |
6
|